According to Danish legislation, as long as the patient identification list (which combines the Civil Personal Registration (CPR) number with the patient-ID number) is still existing, sharing of the data (in a de-identified format) is only allowed once permission from the Danish Data Protection Agency is obtained, which requires a signed data sharing agreement. When the permission for data processing expires (by May 16, 2028), deleting the patient identification list will fully anonymise data. Hereafter all collected data including the data dictionary are planned to be transferred to the Danish National Archives (<https://www.sa.dk/en/>), from where assess to the data can be granted to researchers who provide a methodologically sound proposal, and who are seeking to achieve aims described in the approved proposal. Proposals should be directed to <mailbox@sa.dk> Data requestors will need to sign a data sharing agreement. Additional material is available online in the form of the study protocol (<https://www.ncbi.nlm.nih.gov/pubmed/26492879>), and the informed consent form [www.ctp-net.dk](http://www.ctp-net.dk).

Introduction {#sec006}
============

As the global refugee population is at its highest level ever recorded, with a refugee population of 22.5 million at the end of 2016 \[[@pone.0230300.ref001]\], the pertinence of issues regarding trauma-affected refugees is higher than ever. With an average prevalence of 30% of trauma-related psychiatric illnesses of PTSD and depression in populations from areas of conflicts \[[@pone.0230300.ref002]\] and the prevalence of comorbid pain as high as 80--100% among treatment-seeking trauma-affected refugees \[[@pone.0230300.ref003]\], the complex combination of PTSD, comorbid depression and chronic pain constitutes an often debilitating condition \[[@pone.0230300.ref004]\]. However, few rigorous studies exist on treatment effects for trauma-affected refugees. This is problematic because of the complex conditions for trauma-affected refugees, including prolonged trauma and post-migration stressors, entailing that generalising findings from non-refugee populations to trauma-affected refugees should be done with caution \[[@pone.0230300.ref004],[@pone.0230300.ref005]\].

Based on the mutual maintenance theory \[[@pone.0230300.ref006]\], chronic pain in PTSD populations is a maintaining and sustaining factor in PTSD \[[@pone.0230300.ref006],[@pone.0230300.ref007]\]. Consequently, the treatment and rehabilitation of patients with PTSD should include an integrated assessment and treatment of pain \[[@pone.0230300.ref007]\] as well as increasing activity levels \[[@pone.0230300.ref006]--[@pone.0230300.ref008]\]. In non-refugee PTSD populations, physical acitivty (PA) as intervention has gained growing attention in recent years \[[@pone.0230300.ref009],[@pone.0230300.ref010]\]. While the only Cochrane review on PA as treatment for PTSD (in non-refugee populations) from 2010 concluded that no studies fulfilled the inclusion criteria \[[@pone.0230300.ref010]\], a more recent systematic review and meta-analysis from 2015 on four RCTs on PA for adult, non-refugee populations with PTSD found PA to be significantly more effective in decreasing PTSD and depressive symptoms compared to control conditions. This review, including both exercise and mind-body interventions, found promising results for both types of PA and suggests that PA may be a useful adjunct to standard treatment for people with PTSD \[[@pone.0230300.ref009]\]. To date, there is no evidence on the effect of physical activity (PA) as a part of treatment for trauma-affected refugees. Nonetheless, physical activity in various forms is widely used in addition to or as an integrated part of the treatment offered to this group \[[@pone.0230300.ref011],[@pone.0230300.ref012]\]. There is thus an urgent need for examining the effectiveness of physical activity in treating PTSD and pain in robust, clinical RCTs.

Physical activity in this study, was defined as suggested by Caspersen et al. as "any bodily movement produced by skeletal muscles that results in energy expenditure" \[[@pone.0230300.ref013], page 126\]. Furthermore PA can be divided in two categories: 1. structured exercise \[[@pone.0230300.ref013]\] and 2. mind-body interventions \[[@pone.0230300.ref014]\]. The two categories of PA have different content and methodology, and different theories of working mechanisms, although overlap exists \[[@pone.0230300.ref015]\]. Moreover, the focus on body awareness in mind-body interventions has obtained special attention in the PTSD literature due to theories of body awareness being a central aspect of the treatment of PTSD \[[@pone.0230300.ref016],[@pone.0230300.ref017]\]. Due to the possible different working mechanisms between structured exercise and mind-body interventions in the treatment of PTSD, in this study, we were interested both in studying if adding PA to treatment as usual (TAU) would increase treatment outcome but also if one of these two categories of PA was better than the other. As a mind-body intervention we were interested in studying basic body awareness therapy (BBAT), a mild, body-awareness-oriented physiotherapeutic method \[[@pone.0230300.ref018]--[@pone.0230300.ref020]\]. Improved body awareness has been suggested to be a potential mechanism for the therapeutic effect of mind-body therapies, such as BBAT \[[@pone.0230300.ref017],[@pone.0230300.ref021]\] and BBAT is further one of the most widely used types of PA in the treatment of trauma-affected refugees in Denmark. BBAT has been tested among trauma-affected refugees in a pilot study and in a qualitative study and both found BBAT to add value to the treatment, e.g. improve symptoms of depression and anxiety \[[@pone.0230300.ref022]\] and improve sleep \[[@pone.0230300.ref023]\]. Nevertheless, evidence of the effect of BBAT is still lacking in trauma-affected refugees. We futher chose to study a PA based on structured exercise (in this study called mixed physical activity) as we were interested in studying two different types of PA from each end of the spectrum of PA. The aim of the present study was therefore to investigate if adding either BBAT or mixed physical activity to the treatment as usual (TAU) for trauma-affected refugees with PTSD would increase the treatment effect compared to TAU alone. It was hypothesised that adding physical activity to TAU would augment the treatment effect with respect to mental health symptoms (PTSD, depression, and anxiety), pain, quality of life as well as functional capacity, and body awareness.

Methods {#sec007}
=======

Study design {#sec008}
------------

The study was a 3-armed, pragmatic randomised controlled trial. It was an open-label, parallel group superiority study, allocation ratio of 1:1:1. The trial was conducted at the Competence Centre for Transcultural Psychiatry (CTP), a specialist outpatient clinic treating trauma-affected refugees in the Capital Region of Denmark. Since 2009, CTP has been conducting a series of randomised controlled pragmatic trials \[[@pone.0230300.ref024]--[@pone.0230300.ref026]\]. The target population at CTP comprises trauma-affected refugees (approximately 75%) and migrants with other psychiatric illnesses (approximately 25%). Only the former were included in the present study.

The study was registered with Clinicaltrials.gov (NCT01955538) October 7, 2013. The brief delay in registration with Clinicaltrials.gov (data inclusion starting September 13, 2013) was due to formalities in the registration process. The study was approved by the Ethics Committee of the Capital Region of Denmark July 16, 2013 (H-3-2013-080) as well as the Danish Data Protection Agency (02481 RHP-2013-024). The trial was monitored by Good Clinical Practice (GCP) Unit at Copenhagen University Hospital during the entire study period. The authors confirm that all ongoing and related trials for this intervention are registered. A paper on the study protocol is available: <https://www.ncbi.nlm.nih.gov/pubmed/26492879> \[[@pone.0230300.ref027]\].

Participants {#sec009}
------------

All patients referred to CTP between September 13, 2013, and September 30, 2015 (except for a break in inclusion from October 1, 2014---December 31, 2014), were invited for a 1-3-hour pre-treatment interview with a medical doctor, recording the patient's history of psychiatric symptoms, trauma and social background, and evaluating for eligibility against the following criteria: 18 years or above; recognised as a refugee or family reunified with a refugee; diagnosed with PTSD according to ICD-10 research criteria; having experienced a psychological trauma in the past (e.g. imprisonment, torture, political persecution or war experiences); and motivated for treatment. Written informed consent was obtained from all participants.

The exclusion criteria were: having a psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9); a current abuse of drugs or alcohol (F1x.24-F1x.26) \[[@pone.0230300.ref028]\]; in need of admission to a psychiatric hospital; physical handicaps that made participation in the physical activity impossible; a cardiac arrhythmia identified on the electrocardiogram taken before start of the treatment; or symptoms of heart problems that needed further examination.

Based on pre-treatment interview with a medical doctor, PTSD, depression and personality change after catastrophic event were diagnosed according to a diagnostic algorithm following ICD-10 criteria \[[@pone.0230300.ref028]\]. To exclude psychotic diagnoses, all patients were interviewed with relevant chapters from the Schedules for Clinical Assessment in Neuropsychiatry (SCAN interview) \[[@pone.0230300.ref029]\], by medical doctors who were certified SCAN raters.

All patients fulfilling the inclusion criteria and no exclusion criteria were invited to participate in the study. Patients who did not wish to participate in this study were offered treatment as described in the TAU manual. The complete date range from start of inclusion of participants to completion of treatment programme for all participants was September 13, 2013---January 24, 2017. The pragmatic design of this study primarily consisted of broad inclusion of the target group, only few exclusion criteria and a manualised flexible intervention offered at an outpatient clinic. All patients in need of an interpreter received this assistance and if possible, the same interpreter was used throughout the treatment.

Randomisation and masking {#sec010}
-------------------------

Randomisation was conducted by sequentially, numbered, sealed envelopes, stratified by gender and level of PTSD symptoms (a score \< or \> 3.2 on the Harvard Trauma Questionnaire (HTQ)) by staff unconnected to patient treatment. The Department of Biostatistics at University of Copenhagen, not otherwise involved in the trial, produced a computer-generated randomisation sequence and drew up an anonymous randomisation list. Blinding the intervention was deemed impossible for clinicians and patients due to the nature of the intervention. However, Hamilton Depression and Anxiety (HAM D + A) interviews were conducted before and after treatment by a team of medical students, blinded to intervention group and time of the interview. These raters were trained at CTP and took part in joint ratings every 6--8 weeks to ensure high quality and interrater reliability. The clinicians were not given access to the results of the Hamilton interviews.

Interventions {#sec011}
-------------

The three randomisation groups were:

1.  TAU alone (control group = group C)

2.  TAU + basic body awareness therapy (group B)

3.  TAU + mixed physical activity (group M)

Both add-on treatments comprised individual physiotherapy sessions, one hour a week for 20 weeks. All patients in the two physical activity interventions were encouraged to do home exercises of the relevant physical activity. All clinicians followed profession-specific manuals developed for the target group.

### Treatment as usual (TAU) {#sec012}

The patients were all offered TAU. TAU consisted of approximately 6--7 months (planned) interdisciplinary treatment within a framework of 10 sessions with a medical doctor, and 16 sessions with a psychologist. TAU was divided into two phases. During the first phase, the patient had weekly sessions with a medical doctor, during the second phase monthly sessions with the medical doctor, and weekly sessions with a psychologist. According to needs, typically 1--2 counselling sessions on relevant social issues with a social worker were offered.

In the sessions with the medical doctor the main focus was on initiating pharmacological treatment if needed and providing psychoeducation on a wide range of topics such as explaining symptoms of PTSD and depression; advice on how to improve sleep. When pharmacological treatment was initiated, it was done by following the clinic's algorithm, based on the present knowledge on pharmacological treatment of trauma-affected refugees.

The sessions with the psychologists consisted of one-hour sessions of individual flexible cognitive behavioural therapy (CBT) with elements of acceptance and commitment therapy, stress management and mindfulness. The psychologist manual was developed by the psychologists at CTP using the results and experiences from the recent RCTs at CTP \[[@pone.0230300.ref024],[@pone.0230300.ref026]\]. See also Nordbrandt et al., 2015 \[[@pone.0230300.ref027]\] for further description of TAU.

### The physical activity interventions {#sec013}

The intervention groups B and M were offered 20 weekly sessions with a physiotherapist starting in phase 1. Both physiotherapeutic interventions were mild forms of physical activity but with certain flexibility to regulate the intensity according to the individual patient's capability. Both interventions followed manuals developed in cooperation with physiotherapists experienced in working with the target group. All patients were encouraged to do exercises used in the intervention as homework \[[@pone.0230300.ref027]\]. Each specific exercise was described in the manual, and for every session the actual exercises used and level of participation performed was noted in the patient record. Both physiotherapeutic interventions had a method sheet outlining the different topics/themes, which the physiotherapy could cover, and the topics/themes were connected to a number of specific exercises. Both manuals are available at request from the last author.

-   ***Basic body awareness therapy (BBAT) (group B)***: The exercises comprised slow, guided movements while standing, sitting and lying down, aiming at normalising and improving balance, muscle tension, free breathing and awareness. Only certified BBAT physiotherapists were teaching BBAT.

-   ***Mixed physical activity (group M)***: The intervention included basic exercises focusing on improving strength, endurance, balance and coordination, using simple tools such as water bottles, bicycle, resistance bands, grocery bags etc. The purpose of the tools was that the exercises could easily and inexpensively be practiced at the home of the participants, and could be continued after completion of the treatment programme.

Outcomes {#sec014}
--------

The primary outcome was severity of PTSD symptoms measured on the self-administered Harvard Trauma Questionnaire (HTQ), developed for research on trauma-affected refugees and validated in several populations \[[@pone.0230300.ref030],[@pone.0230300.ref031]\]. Secondary outcomes were the self-administered rating scales Hopkins Symptom Check List (HSCL-25), assessing the severity of anxiety and depression symptoms \[[@pone.0230300.ref032]\], the somatisation scale of Symptom Checklist-90 (SCL-90) \[[@pone.0230300.ref033]\], quality of life evaluated on WHO-5 \[[@pone.0230300.ref034]\] and the Sheehan Disability Scale (SDS) \[[@pone.0230300.ref035]\] for level of functioning. Observer ratings included the Global Assessment of Functioning for symptoms and functioning (GAF-S and -F) \[[@pone.0230300.ref036]\], HoNOS assessing health and social functioning \[[@pone.0230300.ref037]\], and the Hamilton Depression and Anxiety scales (HAM-D and HAM-A) \[[@pone.0230300.ref038]\], which were conducted by blinded assessors. Pain was assessed by two self-administered rating scales: Visual Analogue Scale (VAS); and Brief Pain Inventory short form (BPI) \[[@pone.0230300.ref039],[@pone.0230300.ref040]\]. BPI assesses pain intensity and pain interference and contains a diagram for shading pain location. The pain interference domain is recommended by international consensus (IMMPACT statement) in clinical trials evaluating physical functioning in chronic pain \[[@pone.0230300.ref041]\]. Body awareness was assessed on the self-administered rating scale Multidimensional Assessment of Interoceptive Awareness (MAIA) \[[@pone.0230300.ref017]\]. Functional fitness was assessed by three performance-based physiotherapeutic measures conducted by the physiotherapist: Dynamic Gait Index (DGI) \[[@pone.0230300.ref042]\], Senior Fitness Test \[[@pone.0230300.ref043]\], and De Morton Mobility Index (DEMMI) \[[@pone.0230300.ref044]\]. This range of outcomes was used to enable comparison of our results to the previous studies at CTP and to evaluate on aspects specifically related to PA and pain.

All self-administered outcomes were available in the five main languages of the patients (Danish, Arabic, English, Bosnian/Serbo-Croatian and Farsi). There were a few illiterate (number unknown) participants and also a few participants where the questionnaires had not been translated to their language. These participants were assisted by an interpreter.

Patients were asked to complete most self-administered outcomes three times during the treatment course: at the pre-treatment interview, shortly before initiating phase two and post-treatment. HAM-D and -A were conducted pre- and post-treatment. All three intervention groups had a pre- and a post-treatment assessment with a physiotherapist, mapping physical difficulties and injuries, and conducting the functional fitness tests. Patients completed the self-administered questionnaires MAIA and BPI at these assessments. In this paper, only pre- and post-treatment measurements will be analysed, i.e two data points.

All medical doctors, psychologists and physiotherapists were asked to report to the investigator if becoming aware of any serious adverse events during the trial, whether related to the intervention or not. All serious adverse events discovered were registered and reported to The National Committee on Health Research Ethics.

Concomitant medicine was registered at the start of treatment.

A follow-up was carried out six months after ending the treatment programme. These results will be reported elsewhere.

Statistical analysis {#sec015}
--------------------

Power calculations were conducted with regard to the primary outcome HTQ. The study was initially planned to include approximately 250 patients as a conservative estimate of 200 participants eligible for intention-to-treat analysis with about 65 in each of the three groups would provide power of 81% to detect a group difference corresponding to a standardised difference of ½ SD (Cohen's d) and power to detect a difference of 1 SD of close to 100% (using a 5% level of significance and planning to use contrasts to compare group means in case of a significant overall test of group differences). A difference of less than ½ SD was considered less relevant from a clinical perspective. However, due to a smaller number than expected of male patients with a high HTQ score (which we stratified for in accordance with the average level of HTQ-score in previous RCTs conducted at CTP \[[@pone.0230300.ref024],[@pone.0230300.ref025]\]) a larger number was included. Thus, the final number of included patients was 338.

Pre-treatment characteristics and descriptive data on the treatment were analysed for group differences by Chi-square test with Fisher's exact test and one-way ANOVA.

Pre- and post-treatment ratings were analysed in a mixed model including intervention group and rating time (pre-treatment vs post-treatment) as well as the interaction between time and intervention group. By using Stata's commands "margins" and "contrast", it was possible to estimate means of the treatment groups for pre- and post-treatment ratings and to test pre- post treatment differences in ratings within groups and between-groups differences in pre-post-treatment differences in ratings (corresponding to tests of the interaction between intervention group and rating time). This analysis was carried out both as the primary intention-to-treat analyses of all participants who completed pre-treatment ratings, and in addition on a reduced sample (per-protocol analyses). The per-protocol population was defined as all patients in the control group plus all from B and M who participated in ≥10 physiotherapy sessions.

Two-tailed tests with a 5% level of significance were used in all statistical tests. Robust standard errors were used for conducting the mixed model analyses. Data was entered in the database via double data entry. All analyses were performed using STATA/SE 14.2 for Windows.

Results {#sec016}
=======

A total of 839 patients were screened for the trial. Of these, 338 fulfilled all inclusion criteria and no exclusion criteria and were included in the trial and randomised to either control group (C), basic body awareness therapy (B) or mixed physical activity (M) (C/B/M, n = 110/114/114). Of the 338, 20 patients were excluded during the study period due to exclusion criteria. Thus, 318 patients were eligible for intention-to-treat analyses (ITT-analyses) and 228 patients were eligible for per-protocol analysis (PP-analysis), see Consort Flow Chart, [Fig 1](#pone.0230300.g001){ref-type="fig"}. Mean length of the total treatment course was ten months. Respectively 23, 22 and 32 (C/B/M) patients dropped out of treatment before completing the post-treatment assessment. Average attendance of physiotherapy was ten sessions for both B and M. In the per protocol sample the average number of physiotherapy session in both groups B and M was 14.

![Consort 2010 flow diagram PTF4.](pone.0230300.g001){#pone.0230300.g001}

[Table 1](#pone.0230300.t001){ref-type="table"} illustrates the baseline characteristics of the study population regarding demographics, trauma history, mental health and medication. In addition to PTSD, 294 (97%) of the patients had a comorbid depressive disorder. The functional fitness level on the Senior Fitness Test and DEMMI showed a mean corresponding to 80-90-year-olds at baseline on most subscales. The high levels of further comorbidity appear from [Table 1](#pone.0230300.t001){ref-type="table"}.

10.1371/journal.pone.0230300.t001

###### Pre-treatment characteristics of the control and intervention groups.

![](pone.0230300.t001){#pone.0230300.t001g}

  Pre-treatment characteristics                                                                                    All (N = 318)       Control (N = 104)   Basic body awareness therapy (N = 105)   Mixed physical activity (N = 109)
  ---------------------------------------------------------------------------------------------------------------- ------------------- ------------------- ---------------------------------------- -----------------------------------
                                                                                                                   **Mean (SD)**                                                                    
  **Demographic information**                                                                                                                                                                       
  **Age**                                                                                                          44.6 (10.3)         46.2 (10.4)         43.1 (10.7)                              44.6 (9.5)
  **Years since arrival in Denmark (n = 315)** [\*](#t001fn002){ref-type="table-fn"}                               15.2 (8.6)          15.7 (9.3)          15.1 (8.0)                               14.9 (8.5)
                                                                                                                   **N (%)**                                                                        
  **Male gender**                                                                                                  150 (47.2)          47 (45.2)           49 (46.7)                                54 (49.5)
  **Female gender**                                                                                                168 (52.8)          57 (54.8)           56 (53.3)                                55 (50.5)
  **Refugee camp before arrival in DK (n = 283)** [\*](#t001fn002){ref-type="table-fn"}                            66 (23.3)           23 (25.3)           24 (24.7)                                19 (20.0)
  **Country of origin**                                                                                                                                                                             
  ** Afghanistan**                                                                                                 53 (16.7)           12 (11.5)           20 (19.0)                                21 (19.3)
  ** Chechnya**                                                                                                    11 (3.5)            5 (4.8)             3 (2.9)                                  3 (2.8)
  ** Former Yugoslavia**                                                                                           23 (7.2)            8 (7.7)             8 (7.6)                                  7 (6.4)
  ** Iran**                                                                                                        32 (10.1)           9 (8.7)             9 (8.6)                                  14 (12.8)
  ** Iraq**                                                                                                        99 (31.1)           33 (31.7)           33 (31.4)                                33 (30.3)
  ** Lebanon**                                                                                                     34 (10.7)           14 (13.5)           11 (10.5)                                9 (8.3)
  ** Somalia**                                                                                                     11 (3.5)            4 (3.8)             1 (1.0)                                  6 (5.5)
  ** Syria**                                                                                                       25 (7.9)            10 (9.6)            7 (6.7)                                  8 (7.3)
  ** Other**                                                                                                       30 (9.4)            9 (8.7)             13 (12.4)                                8 (7.3)
  **Trauma history**                                                                                                                                                                                
  ** Torture**                                                                                                     130 (40.9)          44 (42.3)           39 (37.1)                                47 (43.1)
  ** Imprisonment**                                                                                                140 (44.0)          45 (43.3)           42 (40.0)                                53 (48.6)
  ** Soldier (n = 314)** [\*](#t001fn002){ref-type="table-fn"}                                                     83 (26.4)           26 (25.5)           29 (27.6)                                28 (26.2)
  ** Sexual violence (n = 226)** [\*](#t001fn002){ref-type="table-fn"}                                             33 (1.6)            12 (17.1)           11 (1.3)                                 10 (12.7)
  ** Violence from relatives (n = 255)** [\*](#t001fn002){ref-type="table-fn"}                                     85 (33.3)           28 (35.0)           36 (40.9)                                21 (24.1)
  ** Cranial trauma with loss of consciousness (n = 118)** [\*](#t001fn002){ref-type="table-fn"}                   97 (82.2)           31 (76.6)           33 (78.6)                                33 (94.3)
  **Psychosocial status**                                                                                                                                                                           
  ** Presently employed/studying (n = 305)** [\*](#t001fn002){ref-type="table-fn"}                                 26 (8.5)            10 (9.9)            9 (9.0)                                  7 (6.7)
  ** Living alone all the time (n = 307)** [\*](#t001fn002){ref-type="table-fn"}                                   74 (24.1)           25 (24.0)           21 (20.8)                                28 (27.5)
  ** Having children of \< 18 years of age (n = 305)** [\*](#t001fn002){ref-type="table-fn"}                       175 (57.4)          63 (61.8)           55 (55.6)                                57 (54.8)
  ** Duration of education from home country (years) (n = 289)** [\*](#t001fn002){ref-type="table-fn"}                                                                                              
  **\<2**                                                                                                          12 (4.1)            5 (5.1)             7 (7.5)                                  0 (0.0)
  **2--5**                                                                                                         25 (8.6)            9 (9.1)             8 (8.6)                                  8 (8.2)
  **\>5--10**                                                                                                      89 (30.7)           31 (31.3)           26 (28.0)                                32 (32.7)
  **\>10--15**                                                                                                     123 (43.4)          36 (36.4)           43 (46.2)                                44 (44.9)
  **\>15**                                                                                                         40 (36.8)           18 (18.2)           9 (9.7)                                  13 (13.3)
  ** Needing translator during medical doctor sessions (n = 295)** [\*](#t001fn002){ref-type="table-fn"}           184 (62.4)          58 (61.7)           63 (62.4)                                63 (63.0)
  **Diagnoses (ICD-10) additional to PTSD**                                                                                                                                                         
  ** Enduring personality change after catastrophic experience (n = 182)** [\*](#t001fn002){ref-type="table-fn"}   44 (24.2)           17 (31.5)           14 (20.9)                                13 (21.3)
  ** Depression (n = 303)** [\*](#t001fn002){ref-type="table-fn"}                                                  294 (97.0)          97 (98.0)           100 (96.2)                               97 (97.0)
  ** Other psychiatric disorder (n = 201)** [\*](#t001fn002){ref-type="table-fn"}                                  18 (9.0)            4 (6.8)             6 (8.1)                                  8 (11.8)
  ** Psychiatric symptoms since ≥ 10 years (n = 292)** [\*](#t001fn002){ref-type="table-fn"}                       183 (62.7)          57 (60.0)           63 (63.0)                                63 (65.0)
  **Concurrent medicine at beginning of treatment (categorised according to WHO ATC/DDD Index 2018)**:             **All (N = 318)**   **C (N = 104)**     **B (N = 105)**                          **M (N = 109)**
                                                                                                                   **N (%)**                                                                        
  **Antidepressants total (N06A)**                                                                                 102 (32.1)          36 (34.6)           32 (30.5)                                34 (31.2)
  ** SSRI**                                                                                                        64 (20.1)           23 (22.1)           20 (19.1)                                21 (19.3)
  ** SNRI**                                                                                                        19 (6.0)            9 (8.7)             5 (4.8)                                  5 (4.6)
  ** NaSSA**                                                                                                       31 (9.80)           9 (8.7)             8 (7.6)                                  14 (12.8)
  ** Tricyclic antidepressants**                                                                                   14 (.4)             5 (4.8)             7 (6.7)                                  2 (1.8)
  **Antipsychotics (N05A)**                                                                                        28 (8.8)            8 (7.7)             14 (13.3)                                6 (5.5)
  **Anxiolytics (N05B)**                                                                                           11 (3.5)            3 (2.9)             4 (3.8)                                  4 (3.7)
  **Hypnotics and sedatives (N05C)**                                                                               24 (7.6)            7 (6.7)             10 (9.5)                                 7 (6.4)
  **Painkillers/analgesics total**                                                                                 140 (61.4)          41 (39.4)           46 (43.8)                                53 (48.6)
  ** Opioids (N02A+ R05DA04)**                                                                                     44 (13.8)           16 (15.4)           14 (13.3)                                14 (12.8)
  ** Salicylic acids + other analgesics, antipyretics (NSAID, paracetamol) (N02B)**                                109 (34.3)          30 (28.9)           37 (35.2)                                42 (38.5)
  ** Triptanes (N02C)**                                                                                            19 (6.0)            6 (5.8)             4 (3.8)                                  9 (8.3)
  ** Antiepileptics used as analgesics (N03A)**                                                                    12 (3.8)            2 (1.9)             7 (6.7)                                  3 (2.8)

*SD* standard deviation.

\*Data not available for all randomised participants

[Table 2](#pone.0230300.t002){ref-type="table"} illustrates the mixed model analyses on the ITT-sample. On pre-treatment rating scores, there were no significant differences between the groups except for one outcome; a subdomain on the Brief Pain Inventory, the BPI interference (p = 0.0196) ([Table 2](#pone.0230300.t002){ref-type="table"}).

10.1371/journal.pone.0230300.t002

###### Score differences between pre-treatment ratings and post-treatment ratings on the Intention-to-treat population.

![](pone.0230300.t002){#pone.0230300.t002g}

  Rating                 Groups and differences                        Mean pre-treatment score (SE)   Mean post-treatment score (SE)   Difference (SE)                                 P-value
  ---------------------- --------------------------------------------- ------------------------------- -------------------------------- ----------------------------------------------- -----------------------------------------------
  **HTQ**                C                                             3.17 (0.04)                     2.96 (0.06)                      **-0.21 (0.06)**                                0.0003[\*\*](#t002fn003){ref-type="table-fn"}
  B                      3.17 (0.04)                                   3.00 (0.07)                     **-0.17 (0.06)**                 0.0024[\*\*](#t002fn003){ref-type="table-fn"}   
  M                      3.18 (0.04)                                   2.97 (0.07)                     **-0.21 (0.07)**                 0.0015[\*\*](#t002fn003){ref-type="table-fn"}   
  Difference, p-value    0.9778                                        0.9116                          0.8573                           \-                                              
  **HSCL-25**            C                                             3.02 (0.051)                    2.80 (0.07)                      **-0.22 (0.07)**                                0.0017[\*\*](#t002fn003){ref-type="table-fn"}
  B                      2.95 (0.05)                                   2.84 (0.08)                     **-0.11 (0.06)**                 0.0907                                          
  M                      2.98 (0.05)                                   2.86 (0.08)                     **-0.11 (0.08)**                 0.1455                                          
  Difference, p-value    0.6246                                        0.8238                          0.4546                           \-                                              
  **SDS**                C                                             22.61 (0.62)                    22.38 (0.84)                     **-0.23 (0.86)**                                0.7886
  B                      22.40 (0.63)                                  21.80 (0.83)                    **-0.60 (0.81)**                 0.4662                                          
  M                      23.66 (0.54)                                  21.12 (0.89)                    **-2.54 (0.86)**                 0.0032[\*\*](#t002fn003){ref-type="table-fn"}   
  Difference, p-value    0.2536                                        0.5865                          0.1211                           \-                                              
  **WHO-5**              C                                             14.93 (1.59)                    23.18 (2.56)                     **8.25 (2.37)**                                 0.0005[\*\*](#t002fn003){ref-type="table-fn"}
  B                      16.82 (1.47)                                  23.52 (2.52)                    **6.70 (2.44)**                  0.0061[\*\*](#t002fn003){ref-type="table-fn"}   
  M                      16.19 (1.491)                                 25.87 (2.845)                   **9.68 (2.79)**                  0.0005[\*\*](#t002fn003){ref-type="table-fn"}   
  Difference, p-value    0.6768                                        0.7520                          0.7205                           \-                                              
  **Ham-D**              C                                             22.73 (0.65)                    21.75 (0.77)                     **-0.98 (0.76)**                                0.1995
  B                      22.58 (0.53)                                  21.94 (0.83)                    **-0.64 (0.70)**                 0.3606                                          
  M                      21.45 (0.72)                                  20.42 (0.86)                    **-1.03 (0.78)**                 0.1869                                          
  Difference, p-value    0.3464                                        0.3765                          0.9171                           \-                                              
  **Ham-A**              C                                             26.82 (0.85)                    26.79 (0.96)                     **-0.03 (1.06)**                                0.9789
  B                      27.03 (0.7)                                   26.32 (1.0)                     **-0.71 (0.94)**                 0.4500                                          
  M                      25.53 (0.94)                                  25.87 (1.14)                    *0*.*34 (0*.*98)*                0.7278                                          
  Difference, p-value    0.4180                                        0.8260                          0.7342                           \-                                              
  **GAF-F**              C                                             51.63 (0.87)                    55.05 (1.22)                     **3.42 (1.31)**                                 0.0086[\*\*](#t002fn003){ref-type="table-fn"}
  B                      52.47 (0.84)                                  54.62 (1.10)                    **2.15 (1.02)**                  0.0348[\*](#t002fn002){ref-type="table-fn"}     
  M                      50.94 (0.78)                                  54.58 (1.46)                    **3.64 (1.31)**                  0.05990                                         
  Difference, p-value    0.4087                                        0.9564                          0.5990                           \-                                              
  **GAF-S**              C                                             51.27 (0.68)                    55.89 (1.15)                     **4.62 (1.20)**                                 0.0001[\*\*](#t002fn003){ref-type="table-fn"}
  B                      51.88 (0.64)                                  54.64 (0.93)                    **2.76 (0.86)**                  0.0014[\*\*](#t002fn003){ref-type="table-fn"}   
  M                      51.04 (0.69)                                  55.41 (1.45)                    **4.37 (1.34)**                  0.0011[\*\*](#t002fn003){ref-type="table-fn"}   
  Difference, p-value    0.6493                                        0.6889                          0.3667                           \-                                              
  **BPI severity**       C                                             6.37 (0.18)                     6.58 (0.21)                      *0*.*21 (0*.*19)*                               0.2853
  B                      6.16 (0.20)                                   6.39 (0.22)                     *0*.*23 (0*.*18)*                0.1912                                          
  M                      6.49 (0.20)                                   6.71 (0.26)                     *0*.*22 (0*.*20)*                0.2569                                          
  Difference, p-value    0.5112                                        0.6144                          0.9965                           \-                                              
  **BPI interference**   C                                             7.81 (0.17)                     7.54 (0.21)                      **-0.27 (0.23)**                                0.2281
  B                      7.06 (0.24)                                   6.95 (0.28)                     **-0.11 (0.24)**                 0.6407                                          
  M                      7.24 (0.25)                                   7.16 (0.28)                     **-0.07 (0.23)**                 0.7463                                          
  Difference, p-value    0.0196[\*](#t002fn002){ref-type="table-fn"}   0.2250                          0.7992                           \-                                              

SE = standard error

\* p ≤.0.05

\*\* p≤.0.01

**Bold** = Improvement, *Italic* = Deterioration

HTQ, HSCL-25 = 1--4 (1 best score), SDS = 0--10 (0 best score), WHO-5 = 0--100 (100 best score), HAM-D = 0--52 (0 best score), HAM-A = 0--56 (0 best score), GAF-S/-F = 0--100 (100 best score), BPI severity/interference = 0--10 (0 best score).

*HTQ* Harvard Trauma Questionnaire, *HSCL-25* Hopkins Symptom Checklist-25, *SDS* Sheehan Disability Scale, *WHO-5* WHO-5 Well Being Index, *HAM-D/-A* Hamilton Depression/Anxiety Rating scales, *GAF-F/-S* Global assessment of Functioning (Symptom/Function), *BPI severity/interference* Brief Pain Inventory severity/interference.

All means and SEs in [Table 2](#pone.0230300.t002){ref-type="table"} are mixed model estimates and so are the p-values. The p-values in the pre- and post-treatment columns refer to an overall test of the significance mean differences between the three groups (corresponding to an ANOVA F-test). The p-values in the column showing pre-post treatment differences refer to an overall test of the significance of group differences in mean pre-post treatment differences (this test of group differences in pre-post treatment difference corresponds to the statistical test of the time by intervention interaction). Finally, the column with p-values shows p-values corresponding to the pre-post treatment mean difference in each of the three groups.

On the primary outcome HTQ, we found no post-treatment group differences in scores, corresponding to the overall test of mean differences. However, we found significant decline in HTQ scores for all three intervention groups between pre- and post-treatment ratings. The decline was similar in all three groups. Accordingly, there were no significant group differences in change over time (p = 0.8573, [Table 2](#pone.0230300.t002){ref-type="table"}).

For the secondary outcome measures in [Table 2](#pone.0230300.t002){ref-type="table"} (and [S1 Table](#pone.0230300.s001){ref-type="supplementary-material"}) the results were similar. There were no significant pre- or post-treatment group differences, and although most variables showed significant improvement in rating scores over time, there were no significant group differences in changes from pre- to post-treatment scores.

For the DEMMI measure only, the group differences were approaching significance (p = 0.0837) but this reflected deterioration in all three groups ([S1 Table](#pone.0230300.s001){ref-type="supplementary-material"}).

The findings of the mixed model PP-analyses ([S2 Table](#pone.0230300.s002){ref-type="supplementary-material"}) were consistent with the ITT-analysis, which showed no differences between groups on the primary outcome (HTQ); the same tendency of general improvement in all three groups; and no significant differences between groups, except on the BPI shaded score and DEMMI score.

During the study period there were no incidents of serious adverse events related to the interventions. Three patients (all from group B) withdrew from the physical activity and reported it was due to experiencing a deterioration of physical pain which they found related to engaging in the BBAT. Among those patients completing the full treatment program, 14 patients (C/B/M = 1/7/6) reported that their pre-existing physical pain had deteriorated after starting the treatment; expressing either a greater extent of discomfort or direct difficulties taking part in certain elements of the treatment.

Discussion {#sec017}
==========

To our knowledge, this pragmatic RCT is by sample size the largest RCT yet conducted on trauma-affected refugees in an interdisciplinary, clinical setting. Furthermore, we believe it is the first RCT to compare two types of physical activity with TAU for trauma-affected refugees.

The study found overall small but significant improvement over time on all three groups on the primary and on four of the secondary outcomes (WHO, GAF-S, HoNOS, MAIA -not worrying) but in contrast to our hypothesis, we found neither BBAT nor mixed physical activity to significantly increase the treatment effect compared to TAU alone.

The results from the present study seem to differ from the conclusion in a review including four studies of PA as adjunctive treatment for non-refugee populations with PTSD \[[@pone.0230300.ref009]\], which points at an improved treatment effect when using PA as adjunctive treatment. The total number of sessions with PA in the studies included in the review do not differ substantially from the total number of sessions in our study. However, the four populations included in the review are different from the present population, as they are adult veterans; civilians; inpatients; and online recruited. Whether they differed in chronicity from the present population is not clear. However, as mentioned, due to the number of and type of traumas as well as post-migratory stressors that trauma-affected refuges face, conclusions based on other populations do not necessarily apply to trauma-affected refugees. Several studies have previously suggested that treatment effects in trauma-affected refugees are typically smaller than in other trauma-affected populations\[[@pone.0230300.ref024]--[@pone.0230300.ref026], [@pone.0230300.ref045]\].

A question of chronicity? {#sec018}
-------------------------

The question remains whether the difference between the results of the above-mentioned studies and the present study can be explained by the level of chronicity, reflected in number of years in the receiving country at the time of treatment start. In a previous study in the same setting, Sonne et al.\[[@pone.0230300.ref046]\] found improvement in self-reported depression in trauma-affected refugees to be negatively correlated to long duration of mental problems. The mean number of years in Denmark (15.2 years (SD 8.60)) and nearly 63% (n = 183) having psychiatric symptoms for more than 10 years are therefore important facts to consider when comparing the present study to other treatment outcome studies with PTSD populations with less chronicity and comorbidity.

In the Cochrane review from 2017 on PA for chronic pain, the authors concluded that the favourable effects are inconsistent throughout the trials, and with mostly small to moderate effects, and that the present evidence is based on small studies of varying quality \[[@pone.0230300.ref047]\]. Hence, clinically based evidence on PA for pain is still insufficient and the results from this study contribute to filling this knowledge gap.

### Strengths and limitations {#sec019}

The study has important strengths. The sample size of the study makes the results robust, and as the study was a pragmatic trial with broad inclusion criteria conducted in a clinical setting, results of the trial are likely to have a high generalisability to other clinical refugee health care settings. Comparing two different physical activity interventions to a TAU-only-group was a unique possibility to compare the two interventions internally as well as comparing them to TAU. Additionally, BBAT as method was prior to this study tested in a pilot study on the same target group, and the method was found satisfactory and acceptable \[[@pone.0230300.ref022]\]. In the pilot study, BBAT was offered in group sessions, which was the reason for several patients not wishing to participate in the study. In the present study we therefore avoided group sessions as this had been reported to be an obstacle for participation. By using individual treatment sessions, no potential spillover effect of a group could blur the results. Furthermore, the number of sessions in the trial was comparable to other PTSD PA intervention studies \[[@pone.0230300.ref009]\].

However, there were also certain limitations to the study. The attendance rate to the offered PA sessions was rather low. Further, the physical activity in the present study was mild, individually adapted, and with a frequency of once a week (with a maximum of 20 weekly sessions), as it was tailored to fit the functional capacity of the patients. As the level of exercise intensity reached in this study therefore was relatively low and no significant improvements on the functional fitness outcomes were seen, one might ask, if this could explain the lack of effect of M. However, regarding effectiveness, systematic reviews of PA for depression and PTSD \[[@pone.0230300.ref009],[@pone.0230300.ref048]\] show conflicting evidence of effects of high-moderate intensity vs. light-moderate physical activity. As this study was pragmatic, the results do not reflect what is possible in a sample of non-chronic PTSD patients with no comorbidity but contribute to our knowledge about what may realistically be achieved in target groups of chronically ill, trauma-affected refugees. Results from previous randomised studies, the pilot BBAT study as well as clinical experience with the target group, had implications for the design of the present study. The frequency and intensity of the PA was adapted to avoid too many dropouts from treatment. Due to a number of patient-related reasons, including costs for transport to CTP, which was not reimbursed, we could not plan for more than one session a week. Apart from frequency of sessions, also the intenstity of the PA in the sessions was adapted to the capacity of the target group. Manuals were developed based on knowledge and clinical experience with the target group and although a more frequent and intense PA could have been wished for this was not possible. With a higher intensity of PA in the study it is expected that a larger number of the patients would not have been able to participate, while a few might have had more benefit. Future studies that could overcome some of these challenges could look at interventions designed to enhance motivation and thereby attendance to physical activity. Studies on motivational interventions have shown promising results in patients with schizophrenia \[[@pone.0230300.ref049]\].

That said, it does not seem that the frequency alone accounts for the lack of difference between the physiotherapy groups and the TAU group in our study since the PP analyses did not show any difference in between groups either, despite having a higher attendance to physiotherapy sessions (14 sessions in ITT-sample versus ten sessions in PP-sample). Hence, future studies may rather explore potential subpopulations who could benefit from physical activity as a part of their treatment as the present study points to no add-on effect for the clinical populations of trauma-affected refugees with a high degree of comorbidities and chronicity.

The questionnaire MAIA was not pre-tested on the target group in a pilot study, and since some patients reported difficulties understanding the MAIA questions, it raises the issue of the validity of the MAIA results. Also, the diagnosis of PTSD was made based on clinical interviews instead of a validated, structured interview. Furthermore, it was not deemed possible to blind patients or clinicians. Important to note is also that B and M were receiving a much more extensive treatment course than the control group (C), making C less comparable to group B and M regarding the amount of time with a clinician. Meanwhile, bearing in mind the difference in time with a clinician and despite this a lack of differences in treatment effect between the control group versus group B and M, the results of the study become even more convincing.

The results of this present study are on a par with the results of the succession of randomised trials conducted at CTP \[[@pone.0230300.ref024]--[@pone.0230300.ref026]\], showing no superiority in decreasing symptoms of PTSD and about the same size in pre- to post-treatment differences. The previous studies all have similar severity of PTSD at baseline, very high depression comorbidity (\>90%) as well as a similar length of time in the new country. While recognising that the present interventions were only two out of a range of existing PA interventions, this could indicate that on average, in a target group with chronic conditions such as the present, only a certain treatment effect is possible, perhaps regardless of the content of the add-on treatment.

Impact on future treatment {#sec020}
--------------------------

The lack of further improvement found in this study, when adding physical activity to TAU, should be taken into account when planning treatment and developing treatment guidelines for trauma-affected refugees with high levels of symptom severity, comorbidities and chronicity. With the rather low attendance found in this study, there is a need for more knowledge on how to motivate the patients for active participation in PA in order to further study if a higher intensity of treatment could increase the effectiveness. However, these efforts should take the symptom severity, comorbiditites and chonicity in this population into account. It was not deemed possible in this study to increase the intensity and still have a broad inclusion of participants. Thus, further research is needed on the target group, including on the relationship between pain and symptoms of PTSD and between chronicity and symptom improvement, to understand how we in the future can provide more effective treatment for trauma-affected refugees with a high degree of comorbidity and symptom chronicity.

Supporting information {#sec021}
======================

###### Score differences between pre-treatment ratings and post-treatment ratings in the intention-to-treat population.

(DOCX)
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Click here for additional data file.
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Reviewer \#1: The research is carried out with a pragmatic approach. It is well designed and written. Even if the research did not confirm the initial hypothesis, I can remark the following consideration:

Description of the selected population:

The sample size of the research population is meaningful and well selected. The issue of immigration from a war affected areas is an important and discussed problem. That's why this research could contribute to understand the nature of the needs of each individual immigrant. There is a great necessity of planning and implementing health and social programs for all those who are arriving in Europe during these recent years.

Descriptions of the therapeutic programs

While the clinical characteristics of the selected populations have been well described and assessed, before and after the therapeutic programs, the readers have not idea of the quality and the quantity of the activities carried out by the patients in addition to the therapy as usual (TAU). Either the physical activities (PA) and the basic body awareness therapy (BBAT) should be better described in order to design a pragmatic protocol for all those will try to improve and implement the intervention on these kind of patients.

Measuring the efficacy of the therapeutic programs

The research has selected a large number of rating scales. All of them have measured the efficacy of the therapeutic programs. Some were measuring the severity of PTSD and other symptoms of depression and anxiety; others the functional impairment and the pain. Some raining scale has been adopted in order to measure the mobility of patients with many physical limitations. I think the use of the International Classification of Functioning, Disability and Health (ICF WHO 2001) could be recommended to have a complete and satisfactory assessment.

Further investigations

The research found overall small but significant improvement over time on all three groups on the primary and on many secondary outcomes but at contrary to the hypothesis, the researchers didn't find any difference between the control group (with only the TAU) and the experiment ones. Since the study was build up with a strong and well prepared study method, I am suggesting to repeat the research replacing the PA and the BBAT with some kind of participation activities within the local community. Even if appears that the researchers don't care about the participation of the refugees to a local community I think this must be included as part of a therapeutic approach for people affected by PTSD and related outcomes.

Reviewer \#2: First, I would like to compliment the authors with their study, which has been conducted thoroughly. The subject of the study is extremely relevant since it evaluates treatment for a target group that suffers tremendously and does not receive a lot of attention. It is of the utmost importance that the authors state that results from other groups suffering from PTSD are not always applicable to refugees with trauma-related disorders.

Furthermore, the addition of body- and movement-related interventions is of importance when dealing with trauma-related disorders, in which the body as locus of control is so severely damaged.

The manuscript is highly readable.

My questions and remarks are the following:

General comments

Given the fact that two of the intervention studied pertain physical activity, it seems important to define physical activity (see also Rosenbaum et al.). Of the four included trials in the Rosenbaum review, two used a yoga-based intervention.

It is unclear why two different physical activity interventions are offered. It is stated that it is important to evaluate differences between the two, but why are two different activities offered in the first place?

Rosenbaum et al. define physical activity as any bodily movement produced by skeletal muscle requiring energy expenditure, thereby citing Caspersen et al. (1985).

However, BBAT could also be regarded as a body- and movement psychotherapeutic intervention, not aiming in the first place at a better physical activity but on ameliorating body-awareness as first aim. See e.g. Erikson et al. (2007) : Body awareness therapy represents a body-oriented physiotherapeutic approach focusing on both the physical and psychological aspects of body dysfunctions; see also the description in Catalan-Matamoros et al. (2010) on BBAT.

In the title of the manuscript it says: basic body awareness therapy or mixed physical activity, giving the impression that these are differently aimed interventions. However, further in the manuscript they are both shared under physical activity.

Abstract

Line 22: It would be better to define the aim somewhat broader, thereby differentiating the two forms of physical activity and making clear already that there are 3 arms.

Line 28/29: these lines should be rewritten, making clear that both add-on treatments are individual physiotherapy treatments.

Conclusions: could some lines as to the why of the lack of difference be added? (discussion).

It think this would better reflect the importance of the study, although results do not show differences to TAU.

Introduction:

I would suggest to skip the reference to the retracted article (lines 60-65).

I would suggest to make a difference between BBAT and mixed physical activity.

The text now mentions BBAT as a body-awareness oriented therapy in line 67, but in the lines following the effect of physical activity is the main issue.

Then the aim of the study is stated as evaluating if either BBAT or mixed physical activity would increase the treatment effect. But I would think there are thoughts about the differences of the effect and it would strengthen the article to articulate some hypotheses regarding the effect of targeting body awareness in trauma.

Participants

It is not clear to me whether the patients are all outpatients, or may be in day-treatment or in-patients

Line 117: patients who did not wish to participate in this study were offered TAU. Does this mean they were not part of the 110 participants in TAU?? Otherwise it should be made clear in the following section about randomization that these patients (and how many) take part.

Interventions:

These remarks are connected to my other remarks about the difference between BBAT, especially its specific therapeutic goals, and mixed physical activity.

Therefore, I would recommend to describe the two arms separately and not under the common denominator of physical activity. By this subdivision the content of the manuscript will be more according to what is suggested in the title of the manuscript.

Results

Lines 244/245

It seems rather obvious that, given a total time of ten months and an average attendance of ten sessions, so physiotherapy once a month, no effect is to be expected. I think this point should get more attention in the discussion. A heightened frequency and more focus on attendance (attendance being a general problem, see also the literature on physical activity for people with schizophrenia for example) could be a recommendation for the future.

How many sessions were there for the intervention groups? I read 20 weekly sessions starting in phase one (line 159). Does this mean a total of 20 sessions?

Line 250: was the percentage of comorbid depression established by the medical doctor according to ICD 10 criteria compared to the Hamilton depression scores? This seems sensible since the comorbid depression is surprisingly high (even given the fact that depression is the main comorbid disorder in PTSD).

Table 2: The fitness results and the MAIA results are absent in this table, while they are crucial for the measurement of the add-on effects. So, it is not clear which measures are for what reason in the Supporting information.

Discussion

Lines 315-316: I would suggest to delete the remark about the interventions in this study not being different from those in the Rosenbaum review. Interventions as well as populations are all very different in the Rosenbaum review, and are also different from the ones in the present study.

345: duration is long, but frequency is a weakness!

348: frequency of once a week would suggest 10 months = possibly 40 sessions!

356-358 I would suggest to skip these lines and possibly look for other references. The authors rely too much on Rosenbaum et al.

Lines 368-371: the add-ons are different because they use body- and movement interventions and it is strange to suggest that the bodily aspects were already met in the TAU.

Lines 374 and further: I have the impression the authors are disappointed, which I can imagine, but I think it would be worthwhile to think about other options, such as frequency of the add-on treatment, motivational issues, etc.

Impact on future treatment.

The first lines should really be deleted. Adding physical activity 10 times in a ten month treatment and having no effect, does not justify this conclusion.

Reviewer \#3: Present article describes a three-arm RCT to find the efficacy of physical activity as an added component in reducing symptoms of PTSD. Trial recruited 338 patients though there was a significant dropout in two arms. The description of trial is very clear with self-administered HTQ as the primary outcome. The study fall shorts in many other statistical and trial consideration, which I describe bellow.

1\. Why the trial is "pragmatic" is not clear. Please describe it why or take the word out.

2\. How many data points per subject is collected on the course of trial is not clear.

3\. The reason for conducting three-arm superiority trial is not very clear. Note, inclusion of more number of arms increases the problem related to multiple testing. This has effect on sample size and type-1 error which I will describe next.

4\. The power analysis described in line 211-221 is insufficient. Please report standardized effects size (Cohen's d) as it is not clear what does mean by 0.5 SD or 1SD. If I interpret 0.5SD and as Cohen's d=0.5 then it is a moderately large effect size, but in the acceptable range. 1.0 is too large an effect size. It should also describe what statistical test is used and using what statistical model. It is not clear if a main effect is powered or an interaction term!! Since more than two arm is present there is a possibility of two or more co-primary hypothesis, which will require adjustment for multiplicity as otherwise type-1 error will be inflated (\>0.05). This may render sample projected to be inferior. Primary analysis model and the model used for sample size should be same or closely following each other.

5\. Also please mention which software or simulation method is used to do the power analysis.

6\. In line 225-228 many analysis methods are described, but I only see the result of pre-post type comparisons in the table 1 and table 2. Where is time by intervention result reported? Also line 234 is confusing as the result following the line is not reported. There is no table related to mixed-model ANOVA. If the study includes more than 3 observations per subject the mixed-effect model based ANOVA should be the primary result for determining superiority.

7\. ITT and per-protocol analysis both are done and it is not clear which result should be more important. It is sometime confusing and not clear reasoning is mentioned for both.

8\. A major concern near 50% dropout in Arm B and M as presented in Figure 1. From the reason for dropout it seems the dropout are non-ignorable as a result if proper care is not taken the results are prone to selection bias. Neither ITT not PPA can take care of this high attrition. A proper approach will be modelling the Missing Not at Random (MNAR) mechanism. I am really doubtful if this aspect is taken care of.

\*\*\*\*\*\*\*\*\*\*
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Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual -- a pragmatic randomised controlled trial

PLOS ONE

Dear Editor and reviewers

Thank you for offering us to revise our manuscript based on the constructive reviewer comments.

Response to Journal requirements:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Thank you for submitting your clinical trial to PLOS ONE and for providing the name of the registry and the registration number. The information in the registry entry suggests that your trial was registered after patient recruitment began. PLOS ONE strongly encourages authors to register all trials before recruiting the first participant in a study.

As per the journal's editorial policy, please include in the Methods section of your paper:

a\) your reasons for your delay in registering this study (after enrolment of participants started);

b\) confirmation that all related trials are registered by stating: "The authors confirm that all ongoing and related trials for this drug/intervention are registered".

Please also ensure you report the date at which the ethics committee approved the study as well as the complete date range for patient recruitment and follow-up in the Methods section of your manuscript.

Response to Journal requirements:

Thank you for pointing this out. We have now added:

• A brief explanation of the delay in registration at Clinical Trials in the Methods section. "The study was registered with Clinicaltrials.gov (NCT01955538) October 7, 2013. The brief delay in registration with Clinicaltrials.gov (data inclusion starting September 13, 2013) was due to formalities in the registration process."

• In the same section we have added the sentence: "The authors confirm that all ongoing and related trials for this intervention are registered".

• In the Methods section we have also specified the date for the ethics committee approval (July 16, 2013) as well as the complete date range for patient recruitment and follow-up (last follow-up being January 24, 2017).

Reviewer \#1

The research is carried out with a pragmatic approach. It is well designed and written. Even if the research did not confirm the initial hypothesis, I can remark the following consideration:

Description of the selected population:

The sample size of the research population is meaningful and well selected. The issue of immigration from a war affected areas is an important and discussed problem. That's why this research could contribute to understand the nature of the needs of each individual immigrant. There is a great necessity of planning and implementing health and social programs for all those who are arriving in Europe during these recent years.

Descriptions of the therapeutic programs

1.1: While the clinical characteristics of the selected populations have been well described and assessed, before and after the therapeutic programs, the readers have not idea of the quality and the quantity of the activities carried out by the patients in addition to the therapy as usual (TAU). Either the physical activities (PA) and the basic body awareness therapy (BBAT) should be better described in order to design a pragmatic protocol for all those will try to improve and implement the intervention on these kind of patients.

\#1.1 Response: It is true that the description of the exact content of the manuals is not available. We have now added more information regarding the activities carried out and we have also added the following: "Both physiotherapeutic interventions had a method sheet outlining the different topics/themes, which the physiotherapy could cover, and the topics/themes were connected to a number of specific exercises. Both manuals are available at request from the last author."

1.2: Measuring the efficacy of the therapeutic programs

The research has selected a large number of rating scales. All of them have measured the efficacy of the therapeutic programs. Some were measuring the severity of PTSD and other symptoms of depression and anxiety; others the functional impairment and the pain. Some raining scale has been adopted in order to measure the mobility of patients with many physical limitations. I think the use of the International Classification of Functioning, Disability and Health (ICF WHO 2001) could be recommended to have a complete and satisfactory assessment.

\#1.2 Response: We do agree that the ICF contains important information in a population as the present. However, we do believe that most of the aspects of the ICF were covered with the extensive battery of measurements used and that we did succeed with getting a rather complete assessment of the participants. In subsequent studies to the present, we have included the WHODAS. The WHODAS has been described to be an operationalization of the ICF and easier to administer than the ICF.

1.3: Further investigations

The research found overall small but significant improvement over time on all three groups on the primary and on many secondary outcomes but at contrary to the hypothesis, the researchers didn't find any difference between the control group (with only the TAU) and the experiment ones. Since the study was build up with a strong and well prepared study method, I am suggesting to repeat the research replacing the PA and the BBAT with some kind of participation activities within the local community. Even if appears that the researchers don't care about the participation of the refugees to a local community I think this must be included as part of a therapeutic approach for people affected by PTSD and related outcomes.

\#1.3 Response: We fully agree that the life outside a treatment facility is of large importance to this population. However, assessing community activities was outside the scope of this research study. We are presently preparing a randomized study where the intervention focuses on a close collaboration with the municipality, using the WHODAS and where a qualitative sub study will look at participation in the local community.

Reviewer \#2

First, I would like to compliment the authors with their study, which has been conducted thoroughly. The subject of the study is extremely relevant since it evaluates treatment for a target group that suffers tremendously and does not receive a lot of attention.

2.1: It is of the utmost importance that the authors state that results from other groups suffering from PTSD are not always applicable to refugees with trauma-related disorders.

\#2.1 Response: We very much agree the existing evidence on treatment outcome suggests that results from other trauma-affected populations cannot always be transferred to trauma-affected refugees. This is pointed out in the Introduction in the sentence "However, few rigorous studies exist on treatment effects for trauma-affected refugees. This is problematic because of the complex conditions for trauma-affected refugees, including prolonged trauma and postmigration stressors, entailing that generalising findings from non-refugee populations to trauma-affected refugees should be done with caution.". We have added reference to a paper ("From Pioneers to Scientists Challenges in Establishing Evidence-Gathering Models in Torture and Trauma Mental Health Services for Refugees" Carlsson et al, 2014), that discusses this issue in depth.

Further a sentence has been revised and another added including a reference stressing the same issue in the Discussion: "However, as mentioned, due to the number of and type of traumas as well as post-migratory stressors that trauma-affected refuges face, conclusions based on other populations do not necessarily apply to trauma-affected refugees. Several studies have previously suggested that treatment effects in trauma-affected refugees are typically smaller than in other trauma-affected population."

Furthermore, the addition of body- and movement-related interventions is of importance when dealing with trauma-related disorders, in which the body as locus of control is so severely damaged.

The manuscript is highly readable.

My questions and remarks are the following:

General comments

2.2: Given the fact that two of the intervention studied pertain physical activity, it seems important to define physical activity (see also Rosenbaum et al.). Of the four included trials in the Rosenbaum review, two used a yoga-based intervention. It is unclear why two different physical activity interventions are offered. It is stated that it is important to evaluate differences between the two, but why are two different activities offered in the first place?

\#2.2 Response: This is an important issue to address. We have now added a definition of physical activity (PA) and have defined structured exercise and mind body interventions as two sub categories of PA used in the study. The definition of PA is the same as the one below by Caspersen et al.. We have included the definitions in the Introduction section which has been extensively revised. We also now explain in more detail in the Introduction why we chose to include both categories of physical activities in the current trial.

2.3: Rosenbaum et al. define physical activity as any bodily movement produced by skeletal muscle requiring energy expenditure, thereby citing Caspersen et al. (1985).

However, BBAT could also be regarded as a body- and movement psychotherapeutic intervention, not aiming in the first place at a better physical activity but on ameliorating body-awareness as first aim. See e.g. Erikson et al. (2007) : Body awareness therapy represents a body-oriented physiotherapeutic approach focusing on both the physical and psychological aspects of body dysfunctions; see also the description in Catalan-Matamoros et al. (2010) on BBAT.

In the title of the manuscript it says: basic body awareness therapy or mixed physical activity, giving the impression that these are differently aimed interventions. However, further in the manuscript they are both shared under physical activity.

\#2.3 Response: We agree that the definitions could be more clearly described in the manuscript. We use "physical activity" as a concept covering all types of exercise (using the broad definition by Caspersen et al.) and "mixed physical activity" for the intervention developed covering the category: structured exercises. We have now tried to make this distinction clearer throughout the manuscript. Please see also \#2.2 above.

Abstract

2.4: Line 22: It would be better to define the aim somewhat broader, thereby differentiating the two forms of physical activity and making clear already that there are 3 arms.

\#2.4 Response: The aim in the abstract has been reframed as suggested and is now identical to the one in the paper: "The aim of the present study was to investigate if adding either BBAT or mixed physical activity to the treatment as usual (TAU) for trauma-affected refugees with PTSD would increase the treatment effect compared to TAU alone."

2.5: Line 28/29: these lines should be rewritten, making clear that both add-on treatments are individual physiotherapy treatments.

\#2.5 Response: These lines have now been rewritten in order to underline that there are two different individual physiotherapy treatments: "Participants were randomised to receive either individual physiotherapy (basic body awareness therapy (group B) or individual mixed physical activity (group M)) one hour/week for 20 weeks plus TAU, or TAU only (group C)."

2.6: Conclusions: could some lines as to the why of the lack of difference be added? (discussion).

It think this would better reflect the importance of the study, although results do not show differences to TAU.

\#2.6 Response: We have added the following sentence, now also included in the Discussion in the Conclusion: "A large number of the participants in the study have a chronic mental condition, often difficult to treat There is a need for studies on potential subpopulations of trauma-affected refugees who could benefit from physical activity as a part of their treatment."

Introduction:

2.7: I would suggest to skip the reference to the retracted article (lines 60-65).

\#2.7 Response: We have now deleted the sentences regarding the retracted article as well as the reference.

2.8: I would suggest to make a difference between BBAT and mixed physical activity.

The text now mentions BBAT as a body-awareness oriented therapy in line 67, but in the lines following the effect of physical activity is the main issue.

\#2.8 Response: This comment is partly addressed previously by clarifying the definition of physical activity (PA), BBAT and mixed physical activity and the text added in relation to comment 2.3. We have additionally added relevant references. Please see response \#2.3.

Furthermore, we have tried to make the difference between the two PA clearer by revising and adding text in the last part of the Introduction:

"The two categories of PA have different content and methodology, and different theories of working mechanisms, although overlap exists. Moreover, the focus on body awareness in mind-body interventions has obtained special attention in the PTSD literature due to theories of body awareness being a central aspect of the treatment of PTSD. Due to the possible different working mechanisms between structured exercise and mind-body interventions in the treatment of PTSD, in this study, we were interested both in studying if adding PA to treatment as usual (TAU) would increase treatment outcome but also if one of these two categories of PA was better than the other.

2.9: Then the aim of the study is stated as evaluating if either BBAT or mixed physical activity would increase the treatment effect. But I would think there are thoughts about the differences of the effect and it would strengthen the article to articulate some hypotheses regarding the effect of targeting body awareness in trauma.

\#2.9 Response: The specific reasons for targeting body awareness are now further explained, partially by the revision described above in \#2.8 and partially by further revising the last part of the Introduction including relevant references:"Improved body awareness has been suggested to be a potential mechanism for the therapeutic effect of mind-body therapies such as BBAT and BBAT is further one of the most widely used types of PA in the treatment of trauma-affected refugees in Denmark. a mild, body-awareness-oriented."

Participants

2.10: It is not clear to me whether the patients are all outpatients, or may be in day-treatment or in-patients

\#2.10 Response: All patients are out-patients. This is stated in Methods; Study design: "The trial was conducted at the Competence Centre for Transcultural Psychiatry (CTP), a specialist outpatient clinic treating trauma-affected refugees in the Capital Region of Denmark."

2.11: Line 117: patients who did not wish to participate in this study were offered TAU. Does this mean they were not part of the 110 participants in TAU?? Otherwise it should be made clear in the following section about randomization that these patients (and how many) take part.

\#2.11 Response: We are sorry about this confusion. We did not collect any longitudinal data on those that were not a part of the study. These patients were offered the same treatment as the one described as TAU. We have revised the sentence to make this clear: "Patients who did not wish to participate in this study were offered treatment corresponding to TAU".

Interventions:

These remarks are connected to my other remarks about the difference between BBAT, especially its specific therapeutic goals, and mixed physical activity.

Therefore, I would recommend to describe the two arms separately and not under the common denominator of physical activity. By this subdivision the content of the manuscript will be more according to what is suggested in the title of the manuscript.

\#2.12 Response: By now being more explicit in our definition of physical activity as well as mixed physical activity (please see \#2.3) and regarding possible working mechanisms we have tried to avoid any confusion that the lack of clear definitions had previously brought to the manuscript. According to the rather broad definition of physical activity by Caspersen et al. both BBAT and the "mixed physical activity" fit in the definition.

Results

2.13: Lines 244/245

It seems rather obvious that, given a total time of ten months and an average attendance of ten sessions, so physiotherapy once a month, no effect is to be expected. I think this point should get more attention in the discussion. A heightened frequency and more focus on attendance (attendance being a general problem, see also the literature on physical activity for people with schizophrenia for example) could be a recommendation for the future.

\#2.13 Response: This is an important comment. The decision of one weekly session was taken to be able to include as many as possible of the patients that are referred to the clinic to obtain an unselected sample. Many of the attending patients at CTP do not wish to come more than once weekly for a variety of reasons, including the cost of transport from their home to CTP which is not reimbursed. Knowing that frequency could not be more than once a week, we stressed the importance of home exercises, but due to a lack of systematic registering of home exercises we could not analyze if those that were persistent in doing exercises at home had a better outcome. As described in Methods PA was offered weekly from phase 1 and was thus not spread out over ten months, i.e. the frequency was not 1/months but 1/week in the period when PA was offered. from Lastly, the issue of low attendance also calls for attention. We have now carefully included this comment throughout the Discussion. We have also added to the Discussion that future studies could look at interventions designed to enhance motivation for physical activity as shown useful in studies on exercise in patients with schizophrenia spectrum disorder. We have added a relevant reference.

That said it does not seem that the frequency alone accounts for the lack for difference between the physiotherapy groups and the TAU group since the per protocol (PP) analyses did not show any in difference in between groups neither. This is now further outlined in the Discussion section.

2.14: How many sessions were there for the intervention groups? I read 20 weekly sessions starting in phase one (line 159). Does this mean a total of 20 sessions?

\#2.14 Response: Yes, this is correct. Both the mixed physical activity group and the BBAT group were offered 20 sessions each. However, due to non-attendance, as described few participants completed 20 sessions. To clarify this we have now added "offered" to the sentence so that it now reads: "The intervention groups B and M were offered 20 weekly sessions with a physiotherapist starting in phase 1".

2.15: Line 250: was the percentage of comorbid depression established by the medical doctor according to ICD 10 criteria compared to the Hamilton depression scores? This seems sensible since the comorbid depression is surprisingly high (even given the fact that depression is the main comorbid disorder in PTSD).

\#2.15 Response: We are aware of the very high prevalence of comorbid depression and believe that this illustrates the severe mental health problems in the sample. The high prevalence is similar to other randomized studies carried out at CTP. The comorbid depression was established by the medical doctor according to ICD-10 criteria. We have now specified this in the Participants section: "Based on pre-treatment interview with a medical doctor, PTSD, depression and personality change after catastrophic event were diagnosed according to a diagnostic algorithm following ICD-10 criteria."

As explained in Randomisation and masking, all Hamilton Depression Ratings were carried out separately by blinded raters. The results of the Hamilton Depression Ratings also reflect a high level of depressive symptoms. The following sentence has been added to the section: "The clinicians were not given access to the results of the Hamilton interviews."

To underline the high comorbidity with depression we have added the following sentence in the last part of Strength and limitations: "The previous studies all have similar severity of PTSD at baseline, very high depression comorbidity (\>90%) as well as a similar length of time in the new country."

2.16: Table 2: The fitness results and the MAIA results are absent in this table, while they are crucial for the measurement of the add-on effects. So, it is not clear which measures are for what reason in the Supporting information.

\#2.16 Response: With many outcomes we had to choose which ones to include in the main paper and which ones are included in the supplementary material. All tables will be available to all readers. We chose to include our CTP standard ratings in the main document as we expected to find add-on effects on these ratings.

If the editors disagree with this decision, we can of course revise the manuscript accordingly.

Discussion

2.17: Lines 315-316: I would suggest to delete the remark about the interventions in this study not being different from those in the Rosenbaum review. Interventions as well as populations are all very different in the Rosenbaum review, and are also different from the ones in the present study.

\#2.17 Response: We have deleted the sentence stating that the interventions in the studies included in the reviews do not differ substantially from the intervention in the present study. We now have added instead: "The total number of sessions with PA in the studies included in the review do not differ substantially from the total number of sessions in our study."

2.18: 345: duration is long, but frequency is a weakness!

\#2.18 Response: We have now included this in our Discussion. (see also Response \#2.14 above).

2.19: 348: frequency of once a week would suggest 10 months = possibly 40 sessions!

\#2.19 Response: We have now underlined that there were a maximum of 20 weekly sessions in the Strengths and limitations section (although also mentioned in the section The physical activity intervention). Please see also \#2.14 above.

2.20: 356-358 I would suggest to skip these lines and possibly look for other references. The authors rely too much on Rosenbaum et al.

\#2.20 Response: As the review includes studies with 10-12 sessions with a similar frequency as the present we do believe that the review is useful for a comparison as the populations included are very different and we believe this to contribute to the differences found. However, we have modified the text: "The results from the present study seem to differ from the conclusion of a review including 4 studies of PA as adjunctive treatment for non-refugee populations with PTSD \[9\], which points at an improved treatment effect when using PA as adjunctive treatment".

2.21: Lines 368-371: the add-ons are different because they use body- and movement interventions and it is strange to suggest that the bodily aspects were already met in the TAU.

\#2.21 Response: We agree with this comment and believe that the sentences can easily be misunderstood. We have now deleted the specific sentences as the point of a chronic population with a potential limited window for improvement is already made in the manuscript.

2.22: Lines 374 and further: I have the impression the authors are disappointed, which I can imagine, but I think it would be worthwhile to think about other options, such as frequency of the add-on treatment, motivational issues, etc.

\#2.22 Response: We have now in our discussion put more weight into discussing frequency, motivation and also chronicity. Please also see Response \#2.13. The Discussion has been extensively revised.

Impact on future treatment.

2.23: The first lines should really be deleted. Adding physical activity 10 times in a ten month treatment and having no effect, does not justify this conclusion.

\#2.23 Response: We do not believe that there should not be physical activity as a part of treatment offered selected groups of trauma-affected refugees. However, we do believe that the results from the present study should be taken into consideration when planning treatment in similar patient groups with as severe and chronic symptoms. There is a need for more knowledge on who should be offered PA as part of the treatment. This is now stressed, and we have adjusted the sentence regarding treatment planning and treatment guidelines to underline that it implies this patient group.

Reviewer \#3

Present article describes a three-arm RCT to find the efficacy of physical activity as an added component in reducing symptoms of PTSD. Trial recruited 338 patients though there was a significant dropout in two arms. The description of trial is very clear with self-administered HTQ as the primary outcome. The study fall shorts in many other statistical and trial consideration, which I describe bellow.

3.1: Why the trial is "pragmatic" is not clear. Please describe it why or take the word out.

\#3.1 Response: Thank you for pointing this out. A pragmatic RCT mimics usual clinical practice aiming at that results should be as applicable as possible to "real-world health settings". Important criteria for a pragmatic trial are broad inclusion and having few exclusion criteria, which both were the case in the present trial. This has now been clarified in the last part of "Participants": "The pragmatic design of this study primarily consisted of broad inclusion of the target group, only few exclusion criteria and an manualised flexible intervention offered at an outpatient clinic."

3.2: How many data points per subject is collected on the course of trial is not clear.

\#3.2 Response: In this paper only two data points were used: pre- and post-treatment. As stated in page 9, data was also collected for the self-ratings just before phase 2 of treatment. Further as stated at the end of the "Outcomes" section a follow up was carried out six months after ending the treatment programme. The results from the follow-up will be reported elsewhere. To avoid confusion and make the two data points clear, we have made some changes in the order and wording in the Outcomes section. In this paper, only pre- and post-treatment measurements will be analysed, i.e two data points."

3.3: The reason for conducting three-arm superiority trial is not very clear. Note, inclusion of more number of arms increases the problem related to multiple testing. This has effect on sample size and type-1 error which I will describe next.

\#3.3 Response: This remark is related to \#2.9. We have revised the Introduction and among other things added the following: "The two categories of PA have different content and methodology, and different theories of working mechanisms, although overlap exists. Moreover, the focus on body awareness in mind-body interventions has obtained special attention in the PTSD literature due to theories of body awareness being a central aspect of the treatment of PTSD. Due to the possible different working mechanisms between structured exercise and mind-body interventions in the treatment of PTSD, in this study, we were interested both in studying if adding PA to treatment as usual (TAU) would increase treatment outcome but also if one of these two categories of PA was better than the other."

3.4: The power analysis described in line 211-221 is insufficient. Please report standardized effects size (Cohen's d) as it is not clear what does mean by 0.5 SD or 1SD. If I interpret 0.5SD and as Cohen's d=0.5 then it is a moderately large effect size, but in the acceptable range. 1.0 is too large an effect size. It should also describe what statistical test is used and using what statistical model. It is not clear if a main effect is powered or an interaction term!! Since more than two arm is present there is a possibility of two or more co-primary hypothesis, which will require adjustment for multiplicity as otherwise type-1 error will be inflated (\>0.05). This may render sample projected to be inferior. Primary analysis model and the model used for sample size should be same or closely following each other.

\#3.4 Response: Cohen's d is calculated as the group difference divided by the standard deviation, and consequently a d of 0.5 means a group difference corresponding to 0.5 standard deviation -- in other words power calculation for " ½ SD" is the same as power calculation for Cohen's d = 0.5. We have made this point explicit in the revised manuscript. We have also made explicit that the power was calculated based on simple comparison of two independent groups, corresponding to post-treatment group differences. We did not adjust the power calculation for multiple testing, because we first conducted an overall test of significant mean differences between the three groups. It can be argued that the initial power calculation should correspond the statistical analysis (e. g. one-way ANOVA with three groups), but we find that Cohen's d for differences between two groups are easier to interpret and it should also be remembered that the purpose of the power-calculation was to obtain a reasonable estimate of the number of patients to include in the study.

3.5: Also please mention which software or simulation method is used to do the power analysis.

\#3.5 Response: The manuscript reports that all analyses were conducted in Stata. Since procedures for power calculation are now included in major statistical programs, we do not find it necessary to specifically mention that Stata was also used for power analyses. Should the editor disagree, we can of course include this information.

3.6: In line 225-228 many analysis methods are described, but I only see the result of pre-post type comparisons in the table 1 and table 2. Where is time by intervention result reported? Also line 234 is confusing as the result following the line is not reported. There is no table related to mixed-model ANOVA. If the study includes more than 3 observations per subject the mixed-effect model based ANOVA should be the primary result for determining superiority.

\#3.6 Response: The manuscript mentions that "Table 2 illustrates the mixed model analyses on the ITT-sample", and in fact all estimates and p-values in the table are based on the mixed model (the table headline also says that the results are based on the intention-to-treat population). Thus, all means and SEs are mixed model estimates and so are the p-values. The p-values in pre- and post-treatment columns refer to an overall test of the significance mean differences between the three groups (corresponding to an ANOVA F-test). The p-values in the column showing pre-post treatment differences refer to an overall test of the significance of group differences in mean pre-post treatment differences (this test of group differences in pre-post treatment difference corresponds to the statistical test of the time by intervention interaction). Finally, the column with p-values shows p-values corresponding to the pre-post treatment mean difference in each of the three groups.

We find that this table is a compact and informative way of presenting the results of the mixed model analyses and have revised the table foot note to make this clearer to the reader.

3.7: ITT and per-protocol analysis both are done and it is not clear which result should be more important. It is sometime confusing and not clear reasoning is mentioned for both.

\#3.7 Response: The results of the ITT analysis are presented in the manuscript while the results of the per-protocol analysis are presented in an online table. This should clarify the issue, but we have gone through the manuscript to check for any ambiguities and now it explicitly describes how the per-protocol analysis may supplement the ITT analysis. In the Statistical analysis section we have specified that ITT is the primary analysis: "This analysis was carried out both as the primary intention-to-treat analyses of all participants who completed pre-treatment ratings, and in addition on a reduced sample (per-protocol analyses)".

3.8: A major concern near 50% dropout in Arm B and M as presented in Figure 1. From the reason for dropout it seems the dropout are non-ignorable as a result if proper care is not taken the results are prone to selection bias. Neither ITT not PPA can take care of this high attrition. A proper approach will be modelling the Missing Not at Random (MNAR) mechanism. I am really doubtful if this aspect is taken care of.

\#3.8 Response: This is a trial carried out in a "real-life" mental health setting which is reflected in the attendance. However, we do understand the concern of the reviewer. We are though not completely sure if the reviewer might have misunderstood Figure 1. There were 77 who were lost to follow up (n=77 C/B/M 23/22/32) and 20 withdrawn from the study. However, the numbers mentioned above with 50% concern number of completers in Arm B and M. As described in the last section of Statistical analysis. "The per-protocol population was defined as all patients in the control group plus all from B and M who participated in ≥10 physiotherapy sessions."

Thus, we defined completers as those having attended a minimum of ten sessions with a physiotherapist among those offered physiotherapy. Therefore, there could by definition only be completers in the TAU. It is of course worrying that so few actually carried through more than ten sessions with the physiotherapist as to expected outcome and this is now more extensively discussed in the Discussion (see response \#2.13 above).
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Dear Jessica Carlsson Carlsson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Albeit the manuscript presents improvements from the orginal version, there are still some substantial point, dtailed in the reviewers\' reports, that requre attention and proper action.

We would appreciate receiving your revised manuscript by January 31. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Andrea Martinuzzi

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: (No Response)

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#4: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#4: No

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

Reviewer \#4: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: As I said in the first review, the research findings did not support the idea of adding physical activity programme to TAU for refugees affected by PTSD. It appears not important to define the physical activity the authors are talking about.

Reviewer \#2: The manuscript has been largely improved! It has been made clear why two different categories of physical activity have been chosen. Also, the differences between structured exercise and mind-body interventions have been outlined in more detail. Next, other issues I raised in my comments have been addressed satisfactorily. Below I state some remaining, mostly small, questions and comments.

General remark: The manuscript still contains several typos and double spaces. I addressed some below, but I advise to re-read the manuscript.

Abstract:

Lines 41-44

The authors now state: 'A large number of the participants in the study have a chronic mental condition, often difficult to treat.'

However, they do not explain the link between the lack of effect related to PA and the chronic mental condition. So, this phrase does not add much in terms of explanations or hypotheses.

Line 54

'postmigration' should be post-migration

Line 65

'andthe suggests' should be corrected

Line 67

mind body interventions should be mind-body interventions

Lines 80-81

'Physical activity in this study, was defined as suggested by Caspersen et al. "any bodily movement produced by skeletal muscles that results in energy expenditure " \[13\]. '

I think after Caspersen et al. the word 'as' is missing. Furthermore, because this is a quotation, a page number should be added.

'Further' PA can be divided in etc. should be Furthermore,

Lines 151/152

'Patients who did not wish to participate in this study were offered treatment corresponding to TAU'

I would say: 'similar' to TAU, but I am not a native speaker

Line 211

(e.g.. body scan, rotation, the wave).

I suggest to delete these examples, because for the lay person, they do not provide an explanation and only rise more questions. May be apart from the body scan, but a body scan is not a typical BBAT exercise.

Line 216

everyday-like tool should be tools

Line 249

' i.e two data points'.

I think this information is reduntant.

Line 366

'primary and on many secondary outcomes'

Many secondary outcomes is rather vague.

Line 370

4 studies should be four studies

Lines 380-381

'Several studies have previously suggested that treatment effects in

trauma-affected refugees are typically smaller than in other trauma-affected populations\[24-26\].'

These studies have been conducted by some of the present researchers. Therefore, if available, It would be good to add another reference, from another country/group of researchers.

Lines 405-406

'By using individual treatment sessions, no potential spillover effect of a group could blur the results.'

Did the authors also consider the possibility that a groupwise treatment could enhance the effects?

I would like to point out that the motivational intervention cited by the authors in line 436 (reference 46) is also a group intervention !

Line 408

lack for difference should be lack of difference

Reviewer \#4: The manuscript entitled \'Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual -- a pragmatic randomised controlled trial\' with the aim to investigate if adding either BBAT or mixed physical activity to the treatment as usual (TAU) for trauma-affected refugees with PTSD would increase the treatment effect compared to TAU alone.

Comments

Questionnaires

The language version that was used by the patients to be cited and referenced for each questionnaire.

For the baseline characteristics, the breakdown of education level to be provided. A statement on whether they are able to read/write and understand the questionnaire to be stated.

The results presentations should place more emphasis on the comparison of pre and post treatment of each group rather than focusing on the group difference at pre treatment and post treatment respectively altogether. Even though there was no significant different at baseline between the groups, the figures are still different from each other. This may affect on the post treatment value. Also based on CONSORT guidelines, all baseline comparison to be avoided.

Page 11 Line 227, for the sentence \' pre treatment interview, shortly before initiating phase two and at the last treatment\' the word post treatment to be used.

Page 11 Line 244-246, the outcome variable used for the sample size calculation to be stated. Other information to be provided e.g. alpha, mean, which two groups were used, software, formula etc. Post hoc multiple comparison method to be considered in the sample size calculation. There was no information on the attrition rates if it were taken into consideration of the sample size calculation.

Page 12 Line 250 - 251, the sentences to be placed after Line 264.

Page 12 Line 253, 1 tailed or 2 tailed test to be stated. Fishers exact test to be rewritten as Fisher\'s exact test. The level of acceptance significance to be stated.

Page 13 Table 1, at least one decimal point for percentages to be provided. The symbol % to be omitted since it has been indicated on the top. w.loss to be spelled out. F.62.0 to be denoted in the table footnote. The sentence \'There were no significant or borderline significant group differences among the data above\' to be break up and denoted in table footnote. Symbol N for All, group C, B and M on to\[ of table.

Table 2, effect size could be explored. Symbol \<= to be replaced with ≤. Statistical test to be denoted in the table footnote. Decimal points for p value to be standardized.

S1 Table & S2 Table, few figures with 1 decimal point (to be consistent with 2 decimal points).

References list did not conform to the journal format.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: Mia Scheffers

Reviewer \#4: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0230300.r004

Author response to Decision Letter 1

27 Jan 2020
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Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual -- a pragmatic randomised controlled trial

PLOS ONE

Dear Editor and reviewers

Thank you for offering the opportunity to further improve the manuscript based on your comments

Review Comments to the Author (after first revision)

Reviewer \#1: As I said in the first review, the research findings did not support the idea of adding physical activity programme to TAU for refugees affected by PTSD. It appears not important to define the physical activity the authors are talking about.

1\. Response: Adding a definition of physical activity was a request by Reviewer\#2 and therefore kept in the manuscript.

Reviewer \#2: The manuscript has been largely improved! It has been made clear why two different categories of physical activity have been chosen. Also, the differences between structured exercise and mind-body interventions have been outlined in more detail. Next, other issues I raised in my comments have been addressed satisfactorily. Below I state some remaining, mostly small, questions and comments.

2.1 General remark: The manuscript still contains several typos and double spaces. I addressed some below, but I advise to re-read the manuscript.

2.1 Response: The manuscript has been carefully re-read to detect typos and double spaces.

2.2 Abstract:

Lines 41-44

The authors now state: 'A large number of the participants in the study have a chronic mental condition, often difficult to treat.'

However, they do not explain the link between the lack of effect related to PA and the chronic mental condition. So, this phrase does not add much in terms of explanations or hypotheses.

2.2 Response: We do agree that as it stands this sentence does not clearly explain the link. However, due to a limitation in number of words in the abstract (word count 309 with a limit of 300) and as the question of chronicity is elaborated in the Discussion we have now chosen to delete the sentence in the abstract.

2.3 Line 54

'postmigration' should be post-migration

2.3 Response: This has been corrected.

2.4 Line 65

'andthe suggests' should be corrected

2.4 Response: "the" has been deleted.

2.5 Line 67

mind body interventions should be mind-body interventions

2.5 Response: This has been corrected.

2.6 Lines 80-81

'Physical activity in this study, was defined as suggested by Caspersen et al. "any bodily movement produced by skeletal muscles that results in energy expenditure " \[13\]. '

I think after Caspersen et al. the word 'as' is missing. Furthermore, because this is a quotation, a page number should be added.

2.6 Response: The word "as" has now been added. The page number has been added just after the in-text citation.

2.7 'Further' PA can be divided in etc. should be Furthermore

2.7 Response: Further has been changed to Furthermore.

2.8 Lines 151/152

'Patients who did not wish to participate in this study were offered treatment corresponding to TAU'

I would say: 'similar' to TAU, but I am not a native speaker

2.8 Response: The sentence has now been changed to: "Patients who did not wish to participate in this study were offered treatment as described in the TAU manual".

2.9 Line 211

(e.g.. body scan, rotation, the wave).

I suggest to delete these examples, because for the lay person, they do not provide an explanation and only rise more questions. May be apart from the body scan, but a body scan is not a typical BBAT exercise.

2.9 Response: To avoid confusion we have now deleted "e.g.. body scan, rotation, the wave" as suggested.

2.10 Line 216

everyday-like tool should be tools

2.10 Response: Everyday-like tools has been changed to tools.

2.11 Line 249

' i.e two data points'.

I think this information is reduntant.

2.11 Response: "i.e two data points" was added as a response to a question regarding number of data points made by Reviewer \#3 in the first review and is therefore kept in this revision.

2.12 Line 366

'primary and on many secondary outcomes'

Many secondary outcomes is rather vague.

2.12 Response: We agree and "many" has now been changed to the specific number (four) and the names of the outcomes have been added.

"...on the primary and on four of the secondary outcomes (WHO, GAF-S, HoNOS, MAIA -not worrying)..."

2.13 Line 370

4 studies should be four studies

2.13 Response: This has been corrected to four studies.

2.14 Lines 380-381

'Several studies have previously suggested that treatment effects in

trauma-affected refugees are typically smaller than in other trauma-affected populations\[24-26\].'

These studies have been conducted by some of the present researchers. Therefore, if available, It would be good to add another reference, from another country/group of researchers.

2.14 Response: As requested we have added a reference from a separate group of researchers (Ter Heide et al., Eye movement desensitisation and reprocessing therapy v. stabilisation as usual for refugees: randomised controlled trial, Br J Psychiatry 2016).

2.15 Lines 405-406

'By using individual treatment sessions, no potential spillover effect of a group could blur the results.'

Did the authors also consider the possibility that a groupwise treatment could enhance the effects?

I would like to point out that the motivational intervention cited by the authors in line 436 (reference 46) is also a group intervention !

2.15 Response: We did consider the possible advantages of group sessions. However, there was a main reason for not choosing group treatment which is now explained: "Additionally, BBAT as method was prior to this study tested in a pilot study on the same target group, and the method was found satisfactory and acceptable. In the pilot study, BBAT was offered in group sessions, which was the reason for several patients not wishing to participate in the study. In the present study we therefore avoided group sessions as this had been reported to be an obstacle for participation."

2.16 Line 408

lack for difference should be lack of difference

2.16 Response: This has been corrected.

Reviewer \#4: The manuscript entitled \'Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual -- a pragmatic randomised controlled trial\' with the aim to investigate if adding either BBAT or mixed physical activity to the treatment as usual (TAU) for trauma-affected refugees with PTSD would increase the treatment effect compared to TAU alone.

Comments

4.1 Questionnaires

The language version that was used by the patients to be cited and referenced for each questionnaire.

4.1 Response: As stated in page 11: "All self-administered outcomes were available in the five main languages of the patients (Danish, Arabic, English, Bosnian/Serbo-Croatian and Farsi).". There are only few references for the different language versions of the included questionnaires. These have now been included in the section Outcomes (Methods).

4.2 For the baseline characteristics, the breakdown of education level to be provided. A statement on whether they are able to read/write and understand the questionnaire to be stated.

4.2 Response: In the data material the education variable contains information on number of years of education in the home country (\<2 years, 2-5 years, \>5-10 years, \>10-15 years and more than \>15 years). This more detailed presentation of data on education has been inserted in table 1.

Most participants were able to read and fill in the questionnaires themselves. "There were a few illiterate (number unknown) participants and also a few participants where the questionnaires had not been translated to their language. These participants were assisted by an interpreter." This has been added in Outcomes (Methods), page 11. We have also added a sentence regarding assistance by interpreter during treatment at the end of the section Participants (Methods), page 8: "All patients in need of an interpreter received this assistance and if possible, the same interpreter was used throughout the treatment."

4.3 The results presentations should place more emphasis on the comparison of pre and post treatment of each group rather than focusing on the group difference at pre treatment and post treatment respectively altogether. Even though there was no significant different at baseline between the groups, the figures are still different from each other. This may affect on the post treatment value.

4.3 Response: We find that the current table 2 presents all relevant means and pre-post treatment differences. Even though post-treatment group differences are often used as the primary outcome in randomised trials, pre-treatment group differences might affect the post-treatment group differences in absolute scores, and even though p-values for these differences are provided, the reviewer is right to stress the pre-post treatment differences in each group and in particular, the group differences in pre-post treatment changes. The latter group differences are likely to be little affected by pre-treatment differences and are an important test of different effects of the three treatment interventions.

As an alternative we have also analysed the data using a regression model with indicator variables for the three groups and the pre-treatment score as independent variable and the post-treatment score as outcome variable. This analysis -- which fully adjusted for pre-treatment differences among the three groups -- showed no significant group differences in post-treatment means, confirming the results of the mixed model analysis.

4.4 Also based on CONSORT guidelines, all baseline comparison to be avoided.

4.4 Response: We have now deleted the following sentence regarding baseline comparisons: "No significant group differences were seen at baseline on any of the characteristics listed in Table 1." We have furthermore (for the same reason) deleted the sentence: \'There were no significant or borderline significant group differences among the data above" in table 1.

4.5 Page 11 Line 227, for the sentence \' pre treatment interview, shortly before initiating phase two and at the last treatment\' the word post treatment to be used.

4.5 Response: The word post-treatment is now used as suggested.

4.6 Page 11 Line 244-246, the outcome variable used for the sample size calculation to be stated. Other information to be provided e.g. alpha, mean, which two groups were used, software, formula etc. Post hoc multiple comparison method to be considered in the sample size calculation. There was no information on the attrition rates if it were taken into consideration of the sample size calculation.

4.6 Response: The power calculations were conducted with regard to the HTQ, and this has been made more clear in the revised version of the paragraph where we also include the alpha level and a comment on multiple comparison -- although due to lack of significant overall effects comparison of means was not used for the main outcomes. Concerning attrition rates the manuscript makes clear that power should be sufficient with about 200 participants, and that the study -- because of expected attrition - was planned to include 250 participants, but that 338 patients were in fact included.

The revised paragraph on power now reads:

"Power calculations were conducted with regard to the primary outcome HTQ. The study was initially planned to include approximately 250 patients as a conservative estimate of 200 participants eligible for intention-to-treat analysis with about 65 in each of the three groups would provide power of 81% to detect a group difference corresponding to a standardised difference of ½ SD (Cohen's d) and power to detect a difference of 1 SD of close to 100% (using a 5% level of significance and planning to use contrasts to compare group means in case of a significant overall test of group differences). A difference of less than ½ SD was considered less relevant from a clinical perspective. However, due to a smaller number than expected of male patients with a high HTQ score (which we stratified for in accordance with the average level of HTQ-score in previous RCTs conducted at CTP \[24,25\]) a larger number was included. Thus, the final number of included patients was 338."

4.7 Page 12 Line 250 - 251, the sentences to be placed after Line 264.

4.7 Response: These two sentences have been moved to the end of "Statistical analysis" as suggested.

4.8 Page 12 Line 253, 1 tailed or 2 tailed test to be stated. Fishers exact test to be rewritten as Fisher\'s exact test. The level of acceptance significance to be stated.

4.8 Response: In the statistical paragraph the following sentence has been included in the revised version of the manuscript: Two-tailed tests with a 5% level of significance were used in all statistical tests. In addition, the spelling of Fisher's exact test has been corrected

4.9 Page 13 Table 1, at least one decimal point for percentages to be provided. The symbol % to be omitted since it has been indicated on the top. w.loss to be spelled out. F.62.0 to be denoted in the table footnote. The sentence \'There were no significant or borderline significant group differences among the data above\' to be break up and denoted in table footnote. Symbol N for All, group C, B and M on to\[ of table.

4.9 Response:

• One decimal is now provided for all the percentages

• The symbol % has been taken out

• "Cranial trauma with loss of consciousness" is now spelled out.

• The code F62.0 has been deleted from the table as the table does not contain other codes for diagnoses.

• The sentence on significant group differences is taken out (please see response 4.4)

• Symbol N is now inserted for All, group C, B and M in the top of the table.

4.10 Table 2, effect size could be explored. Symbol \<= to be replaced with ≤. Statistical test to be denoted in the table footnote. Decimal points for p value to be standardized.

4.10 Response:

• Effect size: Since table 2 does not show a single significant group difference in absolute post-treatment scores or in changes between pre- and post-treatment scores, it hardly makes sense to calculate effect size. However, several measures show significant changes from pre- to post-treatment scores. Since there are no significant group differences in these changes, it makes sense to calculate estimates of effect size based on the full sample. The range of these effect sizes vary from 0.07 (BPI interference) to 0.57 (GAF-S), using the baseline SD to standardise the changes from pre- to post-treatment. Corresponding to the levels of significance in the table, the largest estimated effect sizes were 0.48 SD (HTQ), 0.53 SD (WHO-5) and 0.57 SD (GAF-S). Since these changes are unrelated to the investigated interventions, they may reflect effects of TAU or non-treatment related factors. Because the focus of the paper is on the effects of the interventions, we have not found it appropriate to discuss these effect estimates in the revised paper, but this can be included if the editor finds that it should.

• The symbol \<= has been replaced with ≤ in table 2, S1 and S2

• Denotation of statistical test: Manuscript table 2 includes the footnote below. We find that this is a very detailed explanation and see no need to expand this description. Should the editor disagree we are of course willing to do so.

"All means and SEs in table 2 are mixed model estimates and so are the p-values. The p-values in the pre- and post-treatment columns refer to an overall test of the significance mean differences between the three groups (corresponding to an ANOVA F-test). The p-values in the column showing pre-post treatment differences refer to an overall test of the significance of group differences in mean pre-post treatment differences (this test of group differences in pre-post treatment difference corresponds to the statistical test of the time by intervention interaction). Finally, the column with p-values shows p-values corresponding to the pre-post treatment mean difference in each of the three groups."

• The decimal points for the p value have been standardised as requested.

4.11 S1 Table & S2 Table, few figures with 1 decimal point (to be consistent with 2 decimal points).

4.11 Response: S1 and S2 have now been carefully looked through and corrected as to inconsistency in number of decimals.

4.12 References list did not conform to the journal format.

4.12 Response: The reference list has been corrected to conform with the journal format.

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0230300.r005

Decision Letter 2

Martinuzzi

Andrea

Academic Editor

© 2020 Andrea Martinuzzi

2020

Andrea Martinuzzi

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

27 Feb 2020

Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual -- a pragmatic randomised controlled trial

PONE-D-19-16080R2

Dear Dr. Carlsson,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Andrea Martinuzzi

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

Reviewer \#4: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Yes

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: Yes

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: Thank you for this important contribution to the field! This study is important for all working with refugees with trauma-related problems!

Reviewer \#4: (No Response)

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: Yes: Mia Scheffers

Reviewer \#4: No

10.1371/journal.pone.0230300.r006
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Academic Editor

© 2020 Andrea Martinuzzi

2020

Andrea Martinuzzi

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

2 Mar 2020
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Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual -- a pragmatic randomised controlled trial

Dear Dr. Carlsson:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.
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